Quadrant Capital Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-27
| Closed | -$1K | – | 2815 |
|
|
2022
Q3 | $1K | Buy |
27
+3
| +13% | +$111 | ﹤0.01% | 2539 |
|
|
2022
Q2 | $1K | Sell |
24
-214
| -90% | -$8.92K | ﹤0.01% | 2410 |
|
|
2022
Q1 | $19K | Buy |
238
+167
| +235% | +$13.3K | ﹤0.01% | 1362 |
|
|
2021
Q4 | $14K | Buy |
71
+55
| +344% | +$10.8K | ﹤0.01% | 1475 |
|
|
2021
Q3 | $4K | Buy |
16
+6
| +60% | +$1.5K | ﹤0.01% | 1951 |
|
|
2021
Q2 | $3K | Hold |
10
| – | – | ﹤0.01% | 2016 |
|
|
2021
Q1 | $3K | Buy |
10
+2
| +25% | +$600 | ﹤0.01% | 1965 |
|
|
2020
Q4 | $2K | Sell |
8
-12
| -60% | -$3K | ﹤0.01% | 1971 |
|
|
2020
Q3 | $5K | Sell |
20
-5
| -20% | -$1.25K | ﹤0.01% | 1552 |
|
|
2020
Q2 | $9K | Sell |
25
-70
| -74% | -$25.2K | ﹤0.01% | 1380 |
|
|
2020
Q1 | $24K | Sell |
95
-3
| -3% | -$758 | ﹤0.01% | 1207 |
|
|
2019
Q4 | $28K | Buy |
98
+11
| +13% | +$3.14K | ﹤0.01% | 1597 |
|
|
2019
Q3 | $22K | Sell |
87
-46
| -35% | -$11.6K | ﹤0.01% | 1564 |
|
|
2019
Q2 | $69K | Buy |
133
+121
| +1,008% | +$62.8K | 0.01% | 1058 |
|
|
2019
Q1 | $5K | Hold |
12
| – | – | ﹤0.01% | 1877 |
|
|
2018
Q4 | $4K | Buy |
12
+1
| +9% | +$333 | ﹤0.01% | 1726 |
|
|
2018
Q3 | $9K | Sell |
11
-11
| -50% | -$9K | ﹤0.01% | 1340 |
|
|
2018
Q2 | $14K | Sell |
22
-5
| -19% | -$3.18K | ﹤0.01% | 1122 |
|
|
2018
Q1 | $40K | Buy |
27
+14
| +108% | +$20.7K | 0.01% | 705 |
|
|
2017
Q4 | $11K | Hold |
13
| – | – | ﹤0.01% | 1142 |
|
|
2017
Q3 | $4K | Buy |
13
+6
| +86% | +$1.85K | ﹤0.01% | 1549 |
|
|
2017
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 1992 |
|
|
2017
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 1633 |
|
|
2016
Q4 | $1K | Sell |
7
-1
| -13% | -$143 | ﹤0.01% | 1749 |
|
|
2016
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1731 |
|
|
2016
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1705 |
|
|
2016
Q1 | $1K | Sell |
8
-16
| -67% | -$2K | ﹤0.01% | 1555 |
|
|
2015
Q4 | $6K | Buy |
+24
| New | +$6K | ﹤0.01% | 995 |
|